Gene · 2237
Papers3,948
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
981 to 1,000 of 3,948
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Mitochondrial DNA Instability in Mammalian Cells. | Antioxid Redox Signal | 2022 | 34015960 | PubTator, text mining | PubMed |
| How Protein Methylation Regulates Steroid Receptor Function. | Endocr Rev | 2022 | 33955470 | PubTator, text mining | PubMed |
| Homology-based repair induced by CRISPR-Cas nucleases in mammalian embryo genome editing. | Protein Cell | 2022 | 33945139 | PubTator, text mining | PubMed |
| Critical DNA damaging pathways in tumorigenesis. | Semin Cancer Biol | 2022 | 33905873 | PubTator, text mining | PubMed |
| PRMT5: a putative oncogene and therapeutic target in prostate cancer. | Cancer Gene Ther | 2022 | 33854218 | PubTator, text mining | PubMed |
| FEN1 Status and Its Correlation with Clinicopathologic Characteristic in Colorectal Cancer. | Comb Chem High Throughput Screen | 2022 | 33797361 | PubTator, text mining | PubMed |
| Breaking the paradigm: early insights from mammalian DNA breakomes. | FEBS J | 2022 | 33792193 | PubTator, text mining | PubMed |
| FEN1 inhibitor synergizes with low-dose camptothecin to induce increased cell killing via the mitochondria mediated apoptotic pathway. | Gene Ther | 2022 | 33414522 | PubTator, text mining | PubMed |
| Molecular and cellular paradigms of multidrug resistance in cancer. | Cancer Rep (Hoboken) | 2022 | 33052041 | PubTator, text mining | PubMed |
| The improved photocatalytic activity of highly expanded MoS2 under visible light emitting diodes. | Nanoscale Adv | 2021 | 36133295 | PubTator, text mining | PubMed |
| DNA folds threaten genetic stability and can be leveraged for chemotherapy. | RSC Chem Biol | 2021 | 35340894 | PubTator, text mining | PubMed |
| Depiction of Aging-Based Molecular Phenotypes With Diverse Clinical Prognosis and Immunological Features in Gastric Cancer. | Front Med (Lausanne) | 2021 | 35178409 | PubTator, text mining | PubMed |
| Berberine Inhibits FOXM1 Dependent Transcriptional Regulation of POLE2 and Interferes With the Survival of Lung Adenocarcinoma. | Front Pharmacol | 2021 | 35173608 | PubTator, text mining | PubMed |
| Controlled Trafficking of Multiple and Diverse Cations Prompts Nucleic Acid Hydrolysis. | ACS Catal | 2021 | 35145762 | PubTator, text mining | PubMed |
| Understanding the Emerging Link Between Circadian Rhythm, Nrf2 Pathway, and Breast Cancer to Overcome Drug Resistance. | Front Pharmacol | 2021 | 35126099 | PubTator, text mining | PubMed |
| Identification of CDK1 as a candidate marker in cutaneous squamous cell carcinoma by integrated bioinformatics analysis. | Transl Cancer Res | 2021 | 35116276 | PubTator, text mining | PubMed |
| IGF2BP2 Regulates MALAT1 by Serving as an N6-Methyladenosine Reader to Promote NSCLC Proliferation. | Front Mol Biosci | 2021 | 35111811 | PubTator, text mining | PubMed |
| Standardizing Patient-Derived Organoid Generation Workflow to Avoid Microbial Contamination From Colorectal Cancer Tissues. | Front Oncol | 2021 | 35083141 | PubTator, text mining | PubMed |
| Comprehensive Pan-Cancer Genomic Analysis Reveals PHF19 as a Carcinogenic Indicator Related to Immune Infiltration and Prognosis of Hepatocellular Carcinoma. | Front Immunol | 2021 | 35069553 | PubTator, text mining | PubMed |
| Specific Human ATR and ATM Inhibitors Modulate Single Strand DNA Formation in Leishmania major Exposed to Oxidative Agent. | Front Cell Infect Microbiol | 2021 | 35059327 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2237/papers?page=50